search
Back to results

Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain

Primary Purpose

Lung Diseases

Status
Not yet recruiting
Phase
Early Phase 1
Locations
Egypt
Study Type
Interventional
Intervention
Bupivacain
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Lung Diseases

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age: > 18 years
  • Patients that reach American socity of anesthesiologist class 1-111
  • Scheduled for VATS surgery under general anesthesia.

Exclusion Criteria:

  • ● Allergy to local anesthetics

    • Patient with pleural inflammation due to recent pneumonia
    • Patients who are unable or unwilling to perform spirometer test
    • Renal dysfunction: (Elevated creatinine > 2 mg\dl)
    • Hepatic dysfunction: (Elevated hepatic enzymes three times above normal value)
    • History of addiction

Sites / Locations

  • Assiut University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Pain managment after VATS

Arm Description

Outcomes

Primary Outcome Measures

Numeric pain scale
Decrease pain assessed by Numeric pain scal

Secondary Outcome Measures

Full Information

First Posted
October 10, 2021
Last Updated
March 7, 2022
Sponsor
Assiut University
search

1. Study Identification

Unique Protocol Identification Number
NCT05282251
Brief Title
Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain
Official Title
Pain Managment After VATS to Reduce Postoperative Pain and Improve Pulmonary Function
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
April 1, 2022 (Anticipated)
Primary Completion Date
December 1, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Thoracic surgery is now common and as other surgeries evolution of minimally invasive techniques is employed. Video-assisted thoracic surgery (VATS) produces little scar but may produce severe pain that may affect the pulmonary function. Many procedure was developed like intercostal nerve block which require injections at multiple levels, Insertion of local anaesthetic (LA) in the surgical drain but that was dangerous due to the large amount of LA and not sufficient to completely eliminate pain. Bupvicaine nebulization, through surgical port which won't make any other wound, thought to be sufficient because Nebulization will enable us better distribution and less amounts of LA. Bupvicaine is local anaesthetic amide group that works by blocking sodium channels thus preventing progression of action potential.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Diseases

7. Study Design

Primary Purpose
Prevention
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pain managment after VATS
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Bupivacain
Intervention Description
Intrapleural Nebulization of local anaesthetic
Primary Outcome Measure Information:
Title
Numeric pain scale
Description
Decrease pain assessed by Numeric pain scal
Time Frame
24 hours

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age: > 18 years Patients that reach American socity of anesthesiologist class 1-111 Scheduled for VATS surgery under general anesthesia. Exclusion Criteria: ● Allergy to local anesthetics Patient with pleural inflammation due to recent pneumonia Patients who are unable or unwilling to perform spirometer test Renal dysfunction: (Elevated creatinine > 2 mg\dl) Hepatic dysfunction: (Elevated hepatic enzymes three times above normal value) History of addiction
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Esam Moubarak Sahin
Phone
01094878158
Ext
01551434651
Email
Emobarak94@gmail.com
Facility Information:
Facility Name
Assiut University
City
Assiut
State/Province
Assuit
ZIP/Postal Code
880
Country
Egypt
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Assuit Assuit University, Bachelor
Phone
01094878158
Ext
01551434651
Email
Emobarak94@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain

We'll reach out to this number within 24 hrs